1. Analysis of clinical and pathological characteristics of retroperitoneal paraganglioma and associated prognostic factors.
- Author
-
Chun C, Song L, Xu G, Shi Q, Li F, and Jia X
- Subjects
- Humans, Male, Female, Middle Aged, Retrospective Studies, Prognosis, Adult, Aged, Survival Rate, Neoplasm Recurrence, Local pathology, Neoplasm Recurrence, Local metabolism, Follow-Up Studies, Young Adult, Succinate Dehydrogenase, Retroperitoneal Neoplasms pathology, Retroperitoneal Neoplasms metabolism, Retroperitoneal Neoplasms surgery, Retroperitoneal Neoplasms mortality, Paraganglioma pathology, Paraganglioma metabolism, Paraganglioma surgery, Paraganglioma mortality, Biomarkers, Tumor metabolism, Biomarkers, Tumor analysis
- Abstract
Background and Objectives: The aim of this study is to explore the long-term prognostic risk factors associated with patients diagnosed with retroperitoneal paraganglioma (RPGL) and examine their clinical and pathological characteristics., Methods: Expressions of biomarkers were identified using immunohistochemistry (IHC) and case databases were retrospectively searched. Survival analysis was performed using Kaplan-Meier and Cox risk regression to identify the factors that influence the postoperative progression-free survival of patients with RPGL., Results: A total of 105 patients, most of whom had tumors situated in the paraaortic region, and whose average tumor size was 8.6 cm, were enrolled in this study. The average follow-up duration was 51 months, with a mortality rate of 19% and a recurrence and metastasis rate of 41.9%. Tumors were assessed using the modified Grading system for Adrenal Pheochromocytoma and Paraganglioma (GAPP), and SDHB, S-100, and Ki-67 were stained using IHC in all cases. Out of the total cases examined, negative in SDHB expression were observed in 18.1% of cases, S-100 expression was negative in 36.2% of cases, and endovascular tumor enboluswas present in approximately 25.7% of cases. The results of the univariate analysis indicated that several factors significantly influenced the progression-free survival of patients with PGL as follow: maximum tumor diameter (>5.5 cm), tumor morphological features, tumor grading (modified GAPP score > 6), SDHB negative, S-100 negative, and expression of proliferation index Ki-67 (>3%) (X
2 = 4.217-27.420, p < 0.05). The results of the multivariate analysis indicated that negative of S-100 (p = 0.021) and SDHB (p = 0.038), as well as intravascular tumor thrombus (p = 0.047) expression were independent risk factors for progression-free survival in patients., Conclusion: RPGL is characterized by diverse biological features and an elevated susceptibility to both recurrence and metastasis. Both SDHB and S-100 can be employed as traditional IHC indicators to predict the metastatic risk of PGL, whereas the tumor histomorphology-endovascular tumor enbolus assists in determining the metastasis risk of RPGL., (© 2024 Wiley Periodicals LLC.)- Published
- 2024
- Full Text
- View/download PDF